Updates on the Treatment of Estrogen Receptor (ER) Positive, Progesterone Receptor (PR) Positive and HER2 Positive Breast Cancer from the 47th Annual San Antonio Breast Cancer Symposium (SABCS)

- Updates from the 47th SABCS on Diagnostic Testing, Biomarkers, Precision Medicine, Grade & Hormone Receptors - What’s New in the Treatment of ER, PR & HER2 Positive Breast Cancer - Updates from SABCS on Hormone & Targeted Therapy - Chemotherapy Updates from SABCS - Investigational New Drugs in Clinical Trials Reported at SABCS: What’s New in Preventing & Managing Treatment Side Effects, Including Discomfort, Neuropathy & Long-Term Effects of Treatment for Breast Cancer - Key Questions to Ask Your Health Care Team - Guidelines to Prepare for Telehealth/Telemedicine Appointments Including Technology, Prepared List of Questions & Discussion of OpenNotes - Quality-of-Life Concerns - Questions for Our Panel of Experts Please note the time for this workshop is 1-2 p.m. ET.